UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKRO
3001
DELISTED
Akero Therapeutics
AKRO
| $10.3M | ﹤0.01% |
371,844
+277,043
| +292% | +$8.39M |
|
3002
iShares iBonds Dec 2027 Term Muni Bond ETF
IBMP
$654M
| $10.3M | ﹤0.01% |
411,482
-52,101
| -11% | -$1.32M |
|
|
BWIN
3003
Baldwin Insurance Group
BWIN
$2.77B
| $10.3M | ﹤0.01% |
266,643
+117,094
| +78% | +$5.46M |
|
3004
iShares US Insurance ETF
IAK
$546M
| $10.3M | ﹤0.01% |
81,716
-28,812
| -26% | -$3.76M |
|
3005
iShares Dow Jones US ETF
IYY
$3.04B
| $10.3M | ﹤0.01% |
72,200
+6,550
| +10% | +$942K |
|
3006
CALL
Atlassian
TEAM
$28B
| $10.3M | ﹤0.01% |
42,400
+37,100
| +700% | +$8.5M |
|
3007
CALL
iShares Semiconductor ETF
SOXX
$47.7B
| $10.3M | ﹤0.01% |
47,794
+15,964
| +50% | +$3.56M |
|
|
ONT
3008
Onterris Inc
ONT
$545M
| $10.3M | ﹤0.01% |
554,991
+492,437
| +787% | +$10.4M |
|
3009
Nuveen Taxable Municipal Income Fund
NBB
$450M
| $10.3M | ﹤0.01% |
686,981
+70,771
| +11% | +$1.13M |
|
3010
Vanguard S&P Mid-Cap 400 Growth ETF
IVOG
$1.67B
| $10.3M | ﹤0.01% |
91,233
+5,739
| +7% | +$674K |
|
3011
Bank of N.T. Butterfield & Son
NTB
$2.44B
| $10.3M | ﹤0.01% |
280,698
+255,414
| +1,010% | +$9.56M |
|
3012
Huron Consulting
HURN
$2.39B
| $10.3M | ﹤0.01% |
82,494
+20,576
| +33% | +$2.41M |
|
3013
PUT
Yum! Brands
YUM
$41.6B
| $10.2M | ﹤0.01% |
76,400
+19,500
| +34% | +$2.64M |
|
3014
CALL
TotalEnergies
TTE
$191B
| $10.2M | ﹤0.01% |
188,000
+117,000
| +165% | +$7.11M |
|
3015
Invesco Dorsey Wright Developed Markets Momentum ETF
PIZ
$752M
| $10.2M | ﹤0.01% |
282,140
+7,455
| +3% | +$279K |
|
3016
Nano X Imaging
NNOX
$71M
| $10.2M | ﹤0.01% |
1,420,378
+1,407,203
| +10,681% | +$9.01M |
|
3017
CALL
Core Scientific
CORZ
$6.76B
| $10.2M | ﹤0.01% |
727,100
+52,100
| +8% | +$770K |
|
3018
Avista
AVA
$3.22B
| $10.2M | ﹤0.01% |
278,721
+134,270
| +93% | +$5.04M |
|
3019
Liberty Global Class A
LBTYA
$3.68B
| $10.2M | ﹤0.01% |
799,497
+742,067
| +1,292% | +$12.4M |
|
3020
Genesis Energy
GEL
$1.86B
| $10.2M | ﹤0.01% |
1,008,189
+172,670
| +21% | +$2.04M |
|
3021
KB Financial Group
KB
$42.6B
| $10.2M | ﹤0.01% |
179,025
+91,349
| +104% | +$5.9M |
|
|
AVDX
3022
DELISTED
AvidXchange
AVDX
| $10.2M | ﹤0.01% |
985,121
+222,803
| +29% | +$2.17M |
|
|
FOLD
3023
DELISTED
Amicus Therapeutics
FOLD
| $10.2M | ﹤0.01% |
1,080,031
+516,059
| +92% | +$5.36M |
|
3024
Revolve Group
RVLV
$1.75B
| $10.2M | ﹤0.01% |
303,186
+194,594
| +179% | +$6.03M |
|
3025
StoneX
SNEX
$8.07B
| $10.1M | ﹤0.01% |
349,468
+193,918
| +125% | +$5.43M |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.